149 related articles for article (PubMed ID: 12948317)
1. Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.
Jonas JB; Kreissig I; Degenring RF
Eur J Ophthalmol; 2003 Jul; 13(6):575-6. PubMed ID: 12948317
[TBL] [Abstract][Full Text] [Related]
2. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
3. Opaque coating of an intraocular lens and regression of iris neovascularization following injection of triamcinolone acetonide into the anterior chamber.
Chen SD; Chen FK; Patel C
Clin Exp Ophthalmol; 2006 Nov; 34(8):803-5. PubMed ID: 17073911
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization.
Jonas JB; Söfker A
J Cataract Refract Surg; 2002 Nov; 28(11):2040-1. PubMed ID: 12457682
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony.
Jonas JB; Hayler JK; Panda-Jonas S
Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(6):464-5. PubMed ID: 11561798
[No Abstract] [Full Text] [Related]
6. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
11. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
Jonas JB; Hayler JK; Söfker A; Panda-Jonas S
J Glaucoma; 2001 Aug; 10(4):284-7. PubMed ID: 11558812
[TBL] [Abstract][Full Text] [Related]
12. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
[No Abstract] [Full Text] [Related]
15. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
Jonas JB; Akkoyun I; Kamppeter B; Kreissig I; Degenring RF
Eye (Lond); 2005 Jan; 19(1):65-71. PubMed ID: 15105817
[TBL] [Abstract][Full Text] [Related]
16. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
17. Primary iris claw IOL retrofixation with intravitreal triamcinolone acetonide in cases of inadequate capsular support.
Kelkar A; Shah R; Vasavda V; Kelkar J; Kelkar S
Int Ophthalmol; 2018 Feb; 38(1):111-117. PubMed ID: 28185180
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide injection in ocular ischemic syndrome.
Klais CM; Spaide RF
Retina; 2004 Jun; 24(3):459-61. PubMed ID: 15187674
[No Abstract] [Full Text] [Related]
19. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Cheng KC; Wu WC; Chen KJ
Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
